Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules
5 Angebote vergleichen
Bester Preis: € 37,80 (vom 02.05.2018)1
Symbolbild
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules (2018)
DE PB NW
ISBN: 9783639718577 bzw. 3639718577, in Deutsch, SPS Apr 2018, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, Rhein-Team Lörrach Ivano Narducci e.K. [57451429], Lörrach, Germany.
Neuware - The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. 68 pp. Englisch.
Von Händler/Antiquariat, Rhein-Team Lörrach Ivano Narducci e.K. [57451429], Lörrach, Germany.
Neuware - The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. 68 pp. Englisch.
2
Symbolbild
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules (2018)
DE PB NW
ISBN: 9783639718577 bzw. 3639718577, in Deutsch, 68 Seiten, SPS, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkosten nach: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, Buchhandlung - Bides GbR, [4124740].
Neuware - The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. - Besorgungstitel - vorauss. Lieferzeit 3-5 Tage. 17.04.2018, Taschenbuch, Neuware, 220x150x4 mm, 117g, 68, Internationaler Versand, offene Rechnung (Vorkasse vorbehalten), PayPal, Banküberweisung.
Von Händler/Antiquariat, Buchhandlung - Bides GbR, [4124740].
Neuware - The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. - Besorgungstitel - vorauss. Lieferzeit 3-5 Tage. 17.04.2018, Taschenbuch, Neuware, 220x150x4 mm, 117g, 68, Internationaler Versand, offene Rechnung (Vorkasse vorbehalten), PayPal, Banküberweisung.
3
Symbolbild
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules
DE PB NW
ISBN: 9783639718577 bzw. 3639718577, in Deutsch, VDM Verlag Dr. Müller, Saarbrücken, Deutschland, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, European-Media-Service Mannheim [1048135], Mannheim, Germany.
Publisher/Verlag: Scholar's Press | The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. | Format: Paperback | Language/Sprache: english | 68 pp.
Von Händler/Antiquariat, European-Media-Service Mannheim [1048135], Mannheim, Germany.
Publisher/Verlag: Scholar's Press | The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. | Format: Paperback | Language/Sprache: english | 68 pp.
4
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules
DE PB NW
ISBN: 9783639718577 bzw. 3639718577, in Deutsch, SPS, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules: The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. Englisch, Taschenbuch.
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules: The European Union protects parallel trade as one of the foundations of the Union. Although the pharmaceutical sector is more sensitive to parallel trade, no distinction is made for this specific industry. Thus, this book tries to cover parallel trade issues in pharmaceutical industry and assess whether there is room for justified restrictions of parallel trade within EU competition rules. A conclusion is drawn, that the EU Courts are cautions to accept different treatment of the pharmaceutical sector. However, it is suggested that the EU Courts would open doors for the justification of restrictions on parallel trade, but only if a direct link between parallel trade and loss in long-run dynamic efficiency is proven by a pharmaceutical company. Furthermore, this will be done only on a case by case basis in order to not sacrifice the goal of achieving an internal market, where the competition rules play an important role. In the light of this conclusion, pharmaceutical companies when thinking of minimizing the risks of competition concerns are advised to consider the important trends and aspects of EU case-law. Englisch, Taschenbuch.
5
Symbolbild
Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules (2018)
EN PB NW
ISBN: 9783639718577 bzw. 3639718577, in Englisch, 68 Seiten, Sps, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandfertig in 4 - 5 Werktagen, Versandkostenfrei. Tatsächliche Versandkosten können abweichen.
Von Händler/Antiquariat, averdo24.
Taschenbuch, Label: Sps, Sps, Produktgruppe: Book, Publiziert: 2018-04-17, Studio: Sps.
Von Händler/Antiquariat, averdo24.
Taschenbuch, Label: Sps, Sps, Produktgruppe: Book, Publiziert: 2018-04-17, Studio: Sps.
Lade…